INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Picard Medical, Inc. of Class Action Lawsuit and Upcoming Deadlines – PMI

Core Viewpoint - A class action lawsuit has been filed against Picard Medical, Inc. for alleged securities fraud and unlawful business practices [2][4]. Group 1: Lawsuit Details - The lawsuit involves allegations that Picard and certain officers and/or directors engaged in securities fraud [2]. - Investors have until April 3, 2026, to request to be appointed as Lead Plaintiff if they purchased Picard securities during the Class Period [2]. Group 2: Stock Price Surge - Picard's stock price increased from its IPO price of $4.00 per share to an all-time high of $13.68 per share before October 23, 2025, without any fundamental news to justify this rise [4]. - Investigations revealed that the stock price was artificially inflated through an illicit social-media promotion scheme, where impersonators made sensational claims to incite buying among retail investors [4]. Group 3: Law Firm Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of fighting for victims of securities fraud and corporate misconduct [5]. - The firm has a track record of recovering multimillion-dollar damages for class members [5].